Illumina
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
CEOJacob Thaysen
CEOJacob Thaysen
Employees10,370
Employees10,370
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1998
Founded1998
Employees10,370
Employees10,370
ILMN Key Statistics
Market cap15.19B
Market cap15.19B
Price-Earnings ratio12.53
Price-Earnings ratio12.53
Dividend yield—
Dividend yield—
Average volume1.38M
Average volume1.38M
High today$100.82
High today$100.82
Low today$97.35
Low today$97.35
Open price$98.15
Open price$98.15
Volume1.38M
Volume1.38M
52 Week high$156.66
52 Week high$156.66
52 Week low$68.70
52 Week low$68.70
ILMN News
Simply Wall St 4d
Does Illumina's EPS Beat Reveal Strength or Mask Challenges in Its Growth Prospects?Illumina recently reported its second quarter results, surpassing analysts’ revenue and EPS expectations despite a slight year-on-year revenue decline. An inte...
TipRanks 5d
Illumina price target lowered to $124 from $126 at RBC CapitalRBC Capital lowered the firm’s price target on Illumina (ILMN) to $124 from $126 and keeps an Outperform rating on the shares as part of a broader research note...
Analyst ratings
50%
of 26 ratingsBuy
38.5%
Hold
50%
Sell
11.5%
People also own
Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.